Mirait One Corp
F:5FO
Mirait One Corp
F:5FO
Price:
14.1
EUR
1.44%
Market Cap:
1.3B
EUR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
5FO Alert
Mirait One Corp
14.1
+0.2 (+1.44%)
| 52 Week Range |
10.4
14.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Mirait One Corp
Balance Sheet
Balance Sheet Decomposition
Mirait One Corp
Mirait One Corp
| Current Assets | 262.6B |
| Cash & Short-Term Investments | 51.9B |
| Receivables | 153.7B |
| Other Current Assets | 57.1B |
| Non-Current Assets | 218.7B |
| Long-Term Investments | 19.2B |
| PP&E | 101.9B |
| Intangibles | 78.2B |
| Other Non-Current Assets | 19.4B |
| Current Liabilities | 123B |
| Accounts Payable | 55.4B |
| Accrued Liabilities | 9.4B |
| Short-Term Debt | 24.2B |
| Other Current Liabilities | 34B |
| Non-Current Liabilities | 108B |
| Long-Term Debt | 69.3B |
| Other Non-Current Liabilities | 38.7B |
Balance Sheet
Mirait One Corp
Mirait One Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
30 303
|
30 284
|
34 550
|
33 748
|
38 206
|
33 543
|
44 764
|
50 929
|
32 482
|
50 036
|
|
| Cash Equivalents |
30 303
|
30 284
|
34 550
|
33 748
|
38 206
|
33 543
|
44 764
|
50 929
|
32 482
|
50 036
|
|
| Total Receivables |
82 250
|
83 461
|
92 765
|
95 542
|
134 589
|
149 263
|
149 884
|
184 435
|
195 246
|
208 778
|
|
| Accounts Receivables |
80 047
|
79 974
|
90 168
|
92 718
|
131 843
|
146 075
|
146 119
|
179 260
|
188 140
|
203 666
|
|
| Other Receivables |
2 203
|
3 487
|
2 597
|
2 824
|
2 746
|
3 188
|
3 765
|
5 175
|
7 106
|
5 112
|
|
| Inventory |
17 444
|
17 281
|
17 607
|
21 398
|
28 400
|
32 758
|
30 789
|
30 916
|
31 717
|
31 097
|
|
| Other Current Assets |
4 286
|
6 086
|
6 401
|
3 898
|
9 890
|
10 148
|
8 057
|
9 855
|
13 061
|
14 740
|
|
| Total Current Assets |
134 283
|
137 112
|
151 323
|
154 586
|
211 085
|
225 712
|
233 494
|
276 135
|
272 506
|
304 651
|
|
| PP&E Net |
30 314
|
31 730
|
34 609
|
44 876
|
78 840
|
82 596
|
86 655
|
91 552
|
93 470
|
100 110
|
|
| PP&E Gross |
30 314
|
31 730
|
34 609
|
44 876
|
78 840
|
82 596
|
86 655
|
91 552
|
93 470
|
100 110
|
|
| Accumulated Depreciation |
19 265
|
20 053
|
21 974
|
23 515
|
28 495
|
32 274
|
35 442
|
39 772
|
44 432
|
49 168
|
|
| Intangible Assets |
2 396
|
1 938
|
3 826
|
3 452
|
3 838
|
3 790
|
4 455
|
16 336
|
18 036
|
37 096
|
|
| Goodwill |
381
|
159
|
3 137
|
3 064
|
3 220
|
2 921
|
3 094
|
20 576
|
20 687
|
38 570
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
18 886
|
19 927
|
20 865
|
21 911
|
27 123
|
30 139
|
22 562
|
16 224
|
17 833
|
19 454
|
|
| Other Long-Term Assets |
6 429
|
4 104
|
4 293
|
6 600
|
7 356
|
6 976
|
8 491
|
14 962
|
14 220
|
20 079
|
|
| Other Assets |
381
|
159
|
3 137
|
3 064
|
3 220
|
2 921
|
3 094
|
20 576
|
20 687
|
38 570
|
|
| Total Assets |
192 700
N/A
|
194 978
+1%
|
218 053
+12%
|
234 489
+8%
|
331 462
+41%
|
352 134
+6%
|
358 751
+2%
|
435 785
+21%
|
436 752
+0%
|
519 960
+19%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
35 929
|
38 670
|
40 772
|
39 399
|
50 894
|
58 737
|
63 212
|
67 789
|
67 707
|
64 011
|
|
| Accrued Liabilities |
4 178
|
4 235
|
4 298
|
4 924
|
7 183
|
7 635
|
8 124
|
8 429
|
8 652
|
11 072
|
|
| Short-Term Debt |
0
|
0
|
710
|
124
|
3 602
|
16 789
|
186
|
50 107
|
21 505
|
75 148
|
|
| Current Portion of Long-Term Debt |
24
|
20
|
26
|
607
|
2 958
|
3 371
|
3 347
|
5 533
|
3 305
|
3 539
|
|
| Other Current Liabilities |
12 512
|
12 586
|
13 306
|
18 593
|
24 271
|
18 206
|
28 149
|
26 825
|
23 897
|
38 902
|
|
| Total Current Liabilities |
52 643
|
55 511
|
59 112
|
63 647
|
88 908
|
104 738
|
103 018
|
158 683
|
125 066
|
192 672
|
|
| Long-Term Debt |
36
|
15
|
16 586
|
18 312
|
23 522
|
7 607
|
6 592
|
6 337
|
36 301
|
38 405
|
|
| Deferred Income Tax |
3 359
|
2 851
|
3 597
|
2 417
|
1 326
|
1 691
|
1 180
|
3 779
|
3 527
|
7 621
|
|
| Minority Interest |
3 324
|
3 649
|
4 704
|
3 486
|
3 123
|
3 287
|
4 934
|
7 116
|
7 487
|
8 109
|
|
| Other Liabilities |
10 478
|
10 002
|
9 921
|
9 369
|
18 147
|
19 388
|
16 638
|
17 749
|
17 553
|
21 174
|
|
| Total Liabilities |
69 840
N/A
|
72 028
+3%
|
93 920
+30%
|
97 231
+4%
|
135 026
+39%
|
136 711
+1%
|
132 362
-3%
|
193 664
+46%
|
189 934
-2%
|
267 981
+41%
|
|
| Equity | |||||||||||
| Common Stock |
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
7 000
|
|
| Retained Earnings |
87 471
|
88 691
|
92 679
|
101 789
|
124 287
|
135 546
|
155 239
|
175 815
|
184 041
|
190 849
|
|
| Additional Paid In Capital |
25 947
|
25 936
|
26 043
|
27 563
|
71 559
|
69 399
|
69 571
|
69 652
|
61 280
|
45 775
|
|
| Unrealized Security Profit/Loss |
3 009
|
0
|
4 063
|
4 738
|
2 930
|
4 869
|
4 562
|
2 913
|
2 631
|
3 589
|
|
| Treasury Stock |
2 626
|
0
|
5 299
|
5 168
|
9 684
|
1 386
|
10 888
|
15 844
|
12 329
|
3 793
|
|
| Other Equity |
2 059
|
265
|
353
|
1 336
|
344
|
5
|
905
|
2 585
|
4 195
|
8 559
|
|
| Total Equity |
122 860
N/A
|
122 950
+0%
|
124 133
+1%
|
137 258
+11%
|
196 436
+43%
|
215 423
+10%
|
226 389
+5%
|
242 121
+7%
|
246 818
+2%
|
251 979
+2%
|
|
| Total Liabilities & Equity |
192 700
N/A
|
194 978
+1%
|
218 053
+12%
|
234 489
+8%
|
331 462
+41%
|
352 134
+6%
|
358 751
+2%
|
435 785
+21%
|
436 752
+0%
|
519 960
+19%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
81
|
81
|
79
|
79
|
102
|
107
|
101
|
99
|
96
|
92
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
